Jazz to buy Chimerix for $935M to get brain tumor drug five months ahead of PDUFAnews2025-03-05T12:39:38+00:00March 5th, 2025|Endpoints News|
Bayer cautions pharma sales dip this year despite major upcoming launchesnews2025-03-05T12:05:35+00:00March 5th, 2025|Endpoints News|
Eli Lilly seeks pitches from US states for slice of $27B manufacturing buildout news2025-03-05T11:11:50+00:00March 5th, 2025|Endpoints News|
Bourla says Pfizer could transfer production to US to sidestep Trump’s tariffsnews2025-03-04T11:42:38+00:00March 4th, 2025|Endpoints News|
GSK, Amgen and AstraZeneca tout Phase 3 data in inflammatory nasal condition news2025-03-03T20:56:47+00:00March 3rd, 2025|Endpoints News|
ICER finds GSK inhalers offer advantages over genericsnews2025-03-03T13:10:38+00:00March 3rd, 2025|Endpoints News|
AbbVie finally enters obesity race with $350M upfront for Gubra’s amylinnews2025-03-03T08:56:11+00:00March 3rd, 2025|Endpoints News|
At least seven drugmakers say they will participate in round two of IRA negotiations news2025-02-28T19:41:28+00:00February 28th, 2025|Endpoints News|
Bipartisan ‘pill penalty’ fix and other bills vie for inclusion in reconciliation packagenews2025-02-28T19:34:05+00:00February 28th, 2025|Endpoints News|
CHMP recommends Regeneron, Novartis drugs that still await FDA approvalnews2025-02-28T17:45:45+00:00February 28th, 2025|Endpoints News|
